Injective, a Layer 1 blockchain focused on financial applications, has reached a milestone with $3.57 billion in daily trading volume for tokenized equities. This marks a significant achievement for a sector that was virtually non-existent two years ago. Injective's iAssets framework allows for the trading of synthetic trackers for major companies like Nvidia, Apple, Microsoft, and Amazon on the Helix decentralized exchange. These instruments track real equity prices via oracles without physical settlement, offering up to 25x leverage. The platform's growth is bolstered by strategic partnerships, including a collaboration with Republic to tokenize pre-IPO equity exposure, which generated $1 billion in trading volume within its first month. Additionally, Injective has partnered with Musicow to tokenize music intellectual property rights, expanding its real-world asset (RWA) infrastructure beyond stock trading. Regulatory developments, such as CFTC-regulated futures for Injective's INJ token and Nasdaq's tokenized trading initiatives, are further supporting the platform's expansion. Despite the impressive trading volume, challenges remain, particularly regarding regulatory compliance and the potential need for synthetic equity trackers to be treated as securities. The ongoing SEC discussions will be crucial in determining the future of permissionless platforms like Helix. Additionally, the reliance on oracle-based pricing introduces counterparty risk, especially at high leverage levels.